Tag: LSP

Neurovascular Company Perfuze Raises €22.5m ($25m) Series A for New Stroke Treatment

Perfuze develops catheter-based technology for treating acute ischemic stroke Financing was led by new investors LSP and Seroba Life Sciences and joined by new investor SV Health Investors and existing investors GALWAY, Ireland–(BUSINESS WIRE)–Perfuze, a medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic stroke, has closed a €22.5 […]